Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

AML Treatment Options: Modulating p53 Pathways, Targeting FLT3 Inhibitors and IDH Mutations & Maintenance Therapy

324 views
March 9, 2020
Comments 0
Login to view comments. Click here to Login